Filing Details

Accession Number:
0000899243-21-043693
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-09 19:39:21
Reporting Period:
2021-11-05
Accepted Time:
2021-11-09 19:39:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1496671 Calithera Biosciences Inc. CALA Pharmaceutical Preparations (2834) 272366329
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1670740 Keith Orford C/O Calithera Biosciences, Inc.
343 Oyster Point Blvd. #200
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-05 30,000 $0.00 196,094 No 4 A Direct
Common Stock Disposition 2021-11-09 51,810 $0.84 144,284 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. The shares of Common Stock were acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.832 to $0.850424, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.